EGFR and non-small cell lung carcinoma: Indeed, in more recent large clinical trials, (e.g. AURA2, AURA3 and FLAURA), it has been demonstrated that it is possible to use cobas® to detect ctDNA with EGFR mutations in locally advanced and metastatic NSCLC.